Skip to content

Prenetics Global Limited (PRE) Company Overview

Company Analysis

Prenetics Global Limited PRE

A comprehensive view of key metrics, scores, and financial health for Prenetics Global Limited

Overview of Prenetics Global Limited

PRE NGM
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics Micro Cap
Prenetics Global Limited (PRE), is a Micro Cap company, in the Diagnostics & Research industry, last closed at $16.47, about 72.0% overvalued vs fair value, +33.4% 1Y return, ranked 939/1145 in sector.
Metrics Rev Growth 479.8% ROE -23.1% Gross Margin 52.8% Div Yield 0.00%
USD 16.47
-7.26%
(Delayed)
• Vol 90d: 78.3%
52-Week Range
Market Cap
$278.96M
Enterprise Value
$219.82M
Overall Score
Overall
Growth
Weak
Profitability
Fair
Health
Weak
Efficiency
Fair
Valuation
Weak
Growth
Weak
Profitability
Fair
Health
Weak
Efficiency
Fair
Valuation
Weak
Completeness: 94%
Confidence: 95%
Updated: Oct 31
Top Beats

Quick Facts

HQ Quarry Bay
Fiscal year Dec 31

Next Events

Earnings Nov 10 Estimated

Fair Value Snapshot

Bear Base Bull
$4
$5
$6
Current: $16.47 -72% vs base

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$92.4M
479.8%%
Gross Profit
$48.8M
425.9%%
Operating Income (GAAP)
-$44.5M
-22.6%%
EBITDA
-$32.2M
19.4%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
52.8%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation


Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
1
Active Leaks
1/1
Improving
0
High Impact
1
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Prenetics Global Limited's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
51
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Key strengths

  • Improving FCF Trend FCF trend score is positive (score 0.96). Improving FCF margin signals compounding operational leverage.
  • Expanding Operating Margin Operating margin trend is positive (score 0.96). Margin expansion confirms commercial leverage is building.

Key risks

  • Weak Capital Return Profile Capital return quality is below peers (score 0.33). Low ROIC raises questions about M&A discipline and pipeline ROI.
  • Weak FCF Generation FCF margin quality lags peers (score 0.28). Below-peer FCF conversion is a MedTech quality warning.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Developing
46

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 87% Coverage
Trade-Off Triangle Visualization A ternary plot showing PRE's balance between Growth (49.8%), Profitability (23.5%), and Safety (26.7%). Growth 50% Safety 27% Profitability 23%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

83th percentile vs peers
83
Key Signals
Rev Growth YoY 4.80 98p Revenue CAGR 3Y 91.5% 95p EPS Growth YoY 27.6% 52p TSR 1.72 97p Asset Growth YoY -3.5% 39p
  • Growth performance in top 20% of peers (percentile: 83)
  • Rev Growth YoY in top 20% of peers (4.80, 98th percentile)
  • Revenue CAGR 3Y in top 20% of peers (91.5%, 95th percentile)
  • D/E Ratio in top 20% of peers (1.1%, 84th percentile)
  • TSR in top 20% of peers (1.72, 97th percentile)

No significant risks identified for this axis.

Profitability

39th percentile vs peers
39
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

44th percentile vs peers
45
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Prenetics Global Limited.

Loading scenario defaults...
Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$4.61
- - -
-72.0% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000